Molecular insights into stress erythropoiesis

Current Opinion in Hematology

Volumn 14, Issue 3, 2007, Pages 215-224

  Socolovsky, Merav ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Apoptosis; Death receptors; Stress erythropoiesis

Indexed keywords

ERYTHROPOIETIN RECEPTOR; FAS ANTIGEN; FAS LIGAND; PROTEIN SH2; PROTEIN TYROSINE PHOSPHATASE SHP 1; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING;

APOPTOSIS; BURST FORMING UNIT E; CELL DIFFERENTIATION; CELL LINEAGE; CELL SURVIVAL; COLONY FORMATION; ERYTHROBLAST; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HOMEOSTASIS; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; STRESS;

ANIMALS; ERYTHROID PROGENITOR CELLS; ERYTHROPOIESIS; LEUKEMIA; MICE; RECEPTORS, ERYTHROPOIETIN; STRESS;

EID: 34247129126     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e3280de2bf1     Document Type: Review

References (80)

1. D'Andrea AD, Lodish HF, Wong GG. Expression cloning of the murine erythropoietin receptor. Cell 1989; 57:277-285.
2. Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood 1999; 94:1864-1877.
3. von Lindern M, Zauner W, Mellitzer G, et al. The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 1999; 94:550-559.
4. Bauer A, Tronche F, Wessely O, et al. The glucocorticoid receptor is required for stress erythropoiesis. Genes Dev 1999; 13:2996-3002.
5. Broudy VC, Lin NL, Priestely GV, et al. Interaction of Stem Cell Factor and its receptor c-kit mediates lodgement and acute expansion of hematopoietic cells in the murine spleen. Blood 1996; 88:75-81.
6. Lenox LE, Perry JM, Paulson RF. BMP4 and Madh5 regulate the erythroid response to acute anemia. Blood 2005; 105:2741-2748.
7. Iscove NN, Sieber F. Erythroid progenitors in mouse bone-marrow detected by macroscopic colony formation in culture. Exp Hematol 1974; 3:32-43.
8. Axelrad AA, McLeod DL, Shreeve MM, Heath DS. Properties of cells that produce erythrocytic colonies in vitro. In: RobinsonWA, editor. Hemopoiesis in culture. Washington DC: U.S. Government Printing Office; 1974. pp. 226-234.
9. Stephenson JR, Axelrad AA, McLeod DL, Shreeve MM. Induction of colonies of hemoglobin-synthesizing cells by erythropoietin in vitro. Proc Natl Acad Sci USA 1971; 68:1542-1546.
10. Wu H, Liu X, Jaenisch R, Lodish HF. Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor. Cell 1995; 83:59-67.
11. Miyamoto T, Iwasaki H, Reizis B, et al. Myeloid or lymphoid promiscuity as a critical step in hematopoietic lineage commitment. Dev Cell 2002; 3:137-147.
12. Forsberg EC, Serwold T, Kogan S, et al. New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors. Cell 2006; 126:415-426. In this paper the authors have characterized the differentiation potential as well as the time lag for expression of fully mature cells, for each of the flow-cytometrically defined hematopoietic progenitors. Real-time PCR shows expression of EpoR in HSC and MEP progenitors.
13. Hara H, Ogawa M. Erthropoietic precursors in mice with phenylhydrazine-induced anemia. Am J Hematol 1976; 1:453-458.
14. Wickrema A, Bondurant MC, Krantz SB. Abundance and stability of erythropoietin receptor mRNA in mouse erythroid progenitor cells. Blood 1991; 78:2269-2275.
15. Wickrema A, Krantz SB, Winkelmann JC, Bondurant MC. Differentiation and erythropoietin receptor gene expression in human erythroid progenitor cells. Blood 1992; 80:1940-1949.
16. Broudy VC, Lin N, Brice M, et al. Erythropoietin receptor characteristics on primary human erythroid cells. Blood 1991; 77:2583-2590.
17. Liu Y, Pop R, Sadegh C, et al. Suppression of Fas-FasL coexpression by erythropoietin mediates erythroblast expansion during the erythropoietic stress response in vivo. Blood 2006; 108:123-133. This paper describes the CD71/Ter119 flow-cytometric assay that allows identification of stress-responsive erythroblast subsets directly in adult hematopoietic tissue. It shows that splenic early erythroblasts continuously undergo Fas-mediated apoptosis in the basal state. This apoptosis is suppressed during stress erythropoiesis, allowing increased erythropoietic rate.
18. Laiosa CV, Stadtfeld M, Graf T. Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol 2006; 24:705-738.
19. Akashi K, Traver D, Miyamoto T, Weissman IL. A clonogenic common myeloid progenitor that gives rise to all myeloid lineages. Nature 2000; 404:193-197.
20. Sanchez M, Weissman IL, Pallavicini M, et al. Differential amplification of murine bipotent megakaryocytic/erythroid progenitor and precursor cells during recovery from acute and chronic erythroid stress. Stem Cells 2006; 24:337-348.
21. Ghinassi B, Sanchez M, Martelli F, et al. The hypomorphic Gata1low mutation alters the proliferation/differentiation potential of the common megakaryocytic-erythroid progenitor. Blood 2006; 109:1460-1471.
22. Terszowski G, Waskow C, Conradt P, et al. Prospective isolation and global gene expression analysis of the erythrocyte colony-forming unit (CFU-E). Blood 2005; 105:1937-1945.
23. Vannucchi AM, Paoletti F, Linari S, et al. Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice. Blood 2000; 95:2559-2568.
24. Remy I, Wilson IA, Michnick SW. Erythropoietin receptor activation by a ligand-induced conformation change. Science 1999; 283:990-993.
25. Livnah O, Stura EA, Middleton SA, et al. Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 1999; 283:987-990.
26. Constantinescu SN, Ghaffari S, Lodish HF. The erythropoietin receptor: structure, activation and intracellular signal transduction. Trends Endocrinol Metab 1999; 10:18-23.
27. Wojchowski DM, Gregory RC, Miller CP, et al. Signal transduction in the erythropoietin receptor system. Exp Cell Res 1999; 253:143-156.
28. Huang LJ, Constantinescu SN, Lodish HF. The N-terminal domain of Janus Kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor. Molecular Cell 2001; 8:1327-1338.
29. Lin CS, Lim SK, D'Agati V, Costantini F. Differential effects of an erythropoietin receptor gene disruption on primitive and definitive erythropoiesis. Genes Devel 1996; 10:154-164.
30. Kieran MW, Perkins A, Orkin S, Zon L. Thrombopoietin rescues in vitro erythroid colony formation from mouse embryos lacking the erythropoietin receptor. Proc Natl Acad Sci USA 1996; 93:9126-9131.
31. Parganas E, Wang D, Stravopodis D, et al. Jak2 is essential for signaling through a variety of cytokine receptors. Cell 1998; 93:385-395.
32. Neubauer H, Cumano A, Muller M, et al. Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis. Cell 1998; 93:397-409.
33. Klingmuller U, Lorenz U, Cantley LC, et al. Specific recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995; 80:729-738.
34. Sarna MK, Ingley E, Busfield SJ, et al. Differential regulation of SOCS genes in normal and transformed erythroid cells. Oncogene 2003; 22:3221-3230.
35. Wojchowski DM, Menon MP, Sathyanarayana P, et al. Erythropoietin-dependent erythropoiesis: new insights and questions. Blood Cell Mol Dis 2006; 36:232-238.
36. Yen CH, Yang YC, Ruscetti SK, et al. Involvement of the ubiquitin-proteasome pathway in the degradation of nontyrosine kinase-type cytokine receptors of IL-9, IL-2, and erythropoietin. J Immunol 2000; 165:6372-6380.
37. Walrafen P, Verdier F, Kadri Z, et al. Both proteasomes and lysosomes degrade the activated erythropoietin receptor. Blood 2005; 105:600-608.
38. Watowich SS, Xie X, Klingmuller U, et al. Erythropoietin receptor mutations associated with familial erythrocytosis cause hypersensitivity to erythropoietin in the heterozygous state. Blood 1999; 94:2530-2532.
39. Divoky V, Liu Z, Ryan TM, et al. Mouse model of congenital polycythemia: homologous replacement of murine gene by mutant human erythropoietin receptor gene. Proc Natl Acad Sci USA 2001; 98:986-991.
40. Tong W, Zhang J, Lodish HF. Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways. Blood 2005; 105:4604-4612.
41. SyedRS, ReidSW,Li C, et al. Efficiency of signalling through cytokine receptors depends critically on receptor orientation. Nature 1998; 395:511-516.
42. Jegalian AG, Acurio A, Dranoff G, Wu H. Erythropoietin receptor haploinsufficiency and in vivo interplay with granulocyte-macrophage colony-stimulating factor and interleukin 3. Blood 2002; 99:2603-2605.
43. Socolovsky M, Dusanter-Fourt I, Lodish HF. The prolactin receptor, as well as severly truncated erythropoietin receptors support differentiation of erythroid progenitors. J Biol Chem 1997; 272:14009-14013.
44. Klingmuller U, Wu H, Hsiao JG, et al. Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. Proc Natl Acad Sci USA 1997; 94:3016-3021.
45. Pircher TJ, Geiger JN, Zhang D, et al. Integrative signaling by minimal erythropoietin receptor forms and c-Kit. J Biol Chem 2001; 276:8995-9002.
46. Miller CP, Heilman DW, Wojchowski DM. Erythropoietin receptor-dependent erythroid colony-forming unit development: capacities of Y343 and phosphotyrosine-null receptor forms. Blood 2002; 99:898-904.
47. Zang H, Sato K, Nakajima H, et al. The distal region and receptor tyrosines of the Epo receptor are nonessential for in vivo erythropoiesis. EMBO J 2001; 20:3156-3166.
48. Menon MP, Karur V, Bogacheva O, et al. Signals for stress erythropoiesis are integrated via an erythropoietin receptor-phosphotyrosine- 343-Stat5 axis. J Clin Invest 2006; 116:683-694. This paper shows that mice expressing a knock-in EpoR allele that lacks a large portion of the cytoplasmic domain and all cytoplasmic tyrosines are deficient in their stress response.
49. L induction. Cell 1999; 98:181-191.
50. -/- mice due to decreased survival of early erythroblasts. Blood 2001; 98:3261-3273.
51. Cui Y, Riedlinger G, Miyoshi K, et al. Inactivation of Stat5 in mouse mammary epithelium during pregnancy reveals distinct functions in cell proliferation, survival, and differentiation. Mol Cell Biol 2004; 24:8037-8047.
52. Baxter EJ, Scott LM, Campbell PJ, et al. Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders. Lancet 2005; 365:1054-1061.
53. Kralovics R, Passamonti F, Buser AS, et al. A gain-of-function mutation of JAK2 in myeloproliferative disorders. N Engl J Med 2005; 352:1779-1790.
54. Levine RL, Wadleigh M, Cools J, et al. Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis. Cancer Cell 2005; 7:387-397.
55. James C, Ugo V, Le Couedic JP, et al. A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera. Nature 2005; 434:1144-1148.
56. Longmore GD, Pharr PN, Lodish HF. A constitutively activated erythropoietin receptor stimulates proliferation and contributes to trasnformation of multipotent, committed nonerythroid and erythroid progenitor cells. Mol Cell Biol 1994; 14:2266-2277.
57. Peschle C, Magli MC, Cillo C, et al. Kinetics of erythroid and myeloid stem cells in posthypoxia polycythaemia. Br J Hematol 1977; 37:345-352.
58. Koury MJ, Bondurant MC. Erythropoietin retards DNA breakdown and prevents programmed death in erythroid progenitor cells. Science 1990; 248:378-381.
59. Gregory CJ, Tepperman AD, McCulloch EA, Till JE. Erythropoietic progenitors capable of colony formation in culture: response of normal and genetically anemic W/WV mice to manipulations of the erythron. J Cell Physiol 1974; 84:1-12.
60. Kelly LL, Koury MJ, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlling rates of erythrocyte production. Blood 1993; 82:2340-2352.
61. Nijhof W, Wierenga PK, Pietens J, Bloem R. Cell kinetic behaviour of a synchronized population of erythroid precursor cells in vitro. Cell Tissue Kinet 1984; 17:629-639.
62. Landschulz KT, Boyer SH, Noyes AN, et al. Onset of erythropoietin response in murine erythroid colony-forming units: assignment to early S-phase in a specific cell generation. Blood 1992; 79:2749-2758.
63. Nijhof W, de Haan G, Pietens J, Dontje B. Mechanistic options of erythropoietin-stimulated erythropoiesis. Exp Hematol 1995; 23:369-375.
64. Koury MJ, Sawyer ST, Bondurant MC. Splenic erythroblasts in anemia-inducing Friend disease: a source of cells for studies of erythropoietin-mediated differentiation. J Cell Physiol 1984; 121:526-532.
65. Sawyer ST, Koury MJ, Bondurant MC. Large-scale procurement of erythropoietin-responsive erythroid cells: assay for biological activity of erythropoietin. Methods Enzymol 1987; 147:340-352.
66. Socolovsky M, Nam H, Fleming MD, et al. Ineffective erythropoiesis in Stat5a(-/-)5b(-/-) mice due to decreased survival of early erythroblasts. Blood 2001; 98:3261-3273.
67. Hoelbl A, Kovacic B, Kerenyi MA, et al. Clarifying the role of Stat5 in lymphoid development and Abelson-induced transformation. Blood 2006; 107:4898-4906.
68. Dolznig H, Grebien F, Deiner EM, et al. Erythroid progenitor renewal versus differentiation: genetic evidence for cell autonomous, essential functions of EpoR, Stat5 and the GR. Oncogene 2006; 25:2890-2900.
69. Kelley LL, Koury MJ, Bondurant MC, et al. Survival or death of individual proerythroblasts results from differing erythropoietin sensitivities: a mechanism for controlled rates of erythrocyte production. Blood 1993; 82:2340-2352.
70. Bouscary D, Pene F, Claessens YE, et al. Critical role for PI 3-kinase in the control of erythropoietin-induced erythroid progenitor proliferation. Blood 2003; 101:3436-3443.
71. Haseyama Y, Sawada K, Oda A, et al. Phosphatidylinositol 3-kinase is involved in the protection of primary cultured human erythroid precursor cells from apoptosis. Blood 1999; 94:1568-1577.
72. Kashii Y, Uchida M, Kirito K, et al. A member of Forkhead family transcription factor, FKHRL1, is one of the downstream molecules of phosphatidylinositol 3-kinase-Akt activation pathway in erythropoietin signal transduction. Blood 2000; 96:941-949.
73. Ghaffari S, Jagani Z, Kitidis C, et al. Cytokines and BCR-ABL mediate suppression of TRAIL-induced apoptosis through inhibition of forkhead FOXO3a transcription factor. Proc Natl Acad Sci USA 2003; 100:6523-6528.
74. Wu H, Klingmuller U, Besmer P, Lodish HF. Interaction of the erythropoietin and stem-cell-factor receptors. Nature 1995; 377:242-246.
75. Kapur R, Majumdar M, Xiao X, et al. Signaling through the interaction of membrane-restricted stem-cell factor and c-kit receptor tyrosine kinase: genetic evidence for a differential role in erythropoiesis. Blood 1998; 91:879-889.
76. Kapur R, Zhang L. A novel mechanism of cooperation between c-kit and erythropoietin receptor. Stem cell factor induces the expression of Stat6 and erythropoietin receptor, resulting in efficeint proliferation and survival by erythropoietin. J Biol Chem 2000; 76:1099-1106.
77. van den Akker E, van Dijk TB, Schmidt U, et al. The Btk inhibitor LFM-A13 is a potent inhibitor of Jak2 kinase activity. Biol Chem 2004; 385:409-413.
78. Shibayama H, Takai E, Matsumura I, et al. Identification of a cytokine-induced antiapoptotic molecule anamorsin essential for definitive hematopoiesis. J Exp Med 2004; 199:581-592.
79. van den Akker E, van Dijk T, Parren-van Amelsvoort M, et al. Tyrosine kinase receptor RON functions downstream of the erythropoietin receptor to induce expansion of erythroid progenitors. Blood 2004; 103:4457-4465.
80. Back J, Dierich A, Bronn C, et al. PU.1 determines the self-renewal capacity of erythroid progenitor cells. Blood 2004; 103:3615-3623.